(Q40336756)

19 September 2017

1 reference

title

Hydralazine and related compounds: chemistry, metabolism, and mode of action (English)

1 reference

19 September 2017

1 reference

Reece PA

1

1 reference

19 September 2017

language of work or name

1 reference

1 January 1981

1 reference

Medicinal Research Reviews

19 September 2017

published in

1 reference

19 September 2017

volume

1

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

73-96

1 reference

Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610010105

Metabolism of budralazine, a new antihypertensive agent. II. Metabolic pathways of budralazine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610010105

Fate of hydralazine in man. I. Reactions under gastric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610010105

Comparative evaluation of the in vitro effects of hydralazine and hydralazine acetonide on arterial smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610010105

Identification of hydrallazine and hydrallazine hydrazone metabolites in human body fluids and quantitative in vitro comparisons of their smooth muscle relaxant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610010105

21 January 2018

Identifiers

DOI

10.1002/MED.2610010105

1 reference

19 September 2017

1 reference